Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
osteogenesis imperfecta
MeSH D010013 - osteogenesis imperfecta
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D030342:
Inborn genetic diseases
4 Companies
3 Drugs
$
Success rate
D003095:
Collagen diseases
97 Companies
14 Drugs
$
Success rate
D010009:
Osteochondrodysplasias
0 Companies
0 Drugs
Success rate
D010013:
Osteogenesis imperfecta
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
33
%
3/9
Phase 2
100
%
7/7
Phase 3
50
%
3/6
Approved:
0
Overall Success rate:
17%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use